Cargando…
Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review
Neuroblastoma is the most frequently diagnosed cancer during the first year of life. This neoplasm originates from neural crest cells derived from the sympathetic nervous system, adrenal medulla, or paraspinal ganglia. The clinical presentation can vary from an asymptomatic mass to symptoms resultin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562625/ https://www.ncbi.nlm.nih.gov/pubmed/37823059 http://dx.doi.org/10.3389/fonc.2023.1254322 |
_version_ | 1785118169109626880 |
---|---|
author | Alpuim Costa, Diogo Gonçalves-Nobre, J. Guilherme Sampaio-Alves, Mafalda Guerra, Nuno Arana Ribeiro, Joana Espiney Amaro, Carla |
author_facet | Alpuim Costa, Diogo Gonçalves-Nobre, J. Guilherme Sampaio-Alves, Mafalda Guerra, Nuno Arana Ribeiro, Joana Espiney Amaro, Carla |
author_sort | Alpuim Costa, Diogo |
collection | PubMed |
description | Neuroblastoma is the most frequently diagnosed cancer during the first year of life. This neoplasm originates from neural crest cells derived from the sympathetic nervous system, adrenal medulla, or paraspinal ganglia. The clinical presentation can vary from an asymptomatic mass to symptoms resulting from local invasion and/or spread of distant disease spread. The natural history of neuroblastoma is highly variable, ranging from relatively indolent biological behavior to a high-risk clinical phenotype with a dismal prognosis. Age, stage, and biological features are important prognostic risk stratification and treatment assignment prognostic factors. The multimodal therapy approach includes myeloablative chemotherapy, radiotherapy, immunotherapy, and aggressive surgical resection. Hyperbaric oxygen therapy (HBOT) has been proposed as a complementary measure to overcome tumor hypoxia, which is considered one of the hallmarks of this cancer treatment resistance. This article aims to review the relevant literature on the neuroblastoma pathophysiology, clinical presentation, and different biological and genetic profiles, and to discuss its management, focusing on HBOT. |
format | Online Article Text |
id | pubmed-10562625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105626252023-10-11 Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review Alpuim Costa, Diogo Gonçalves-Nobre, J. Guilherme Sampaio-Alves, Mafalda Guerra, Nuno Arana Ribeiro, Joana Espiney Amaro, Carla Front Oncol Oncology Neuroblastoma is the most frequently diagnosed cancer during the first year of life. This neoplasm originates from neural crest cells derived from the sympathetic nervous system, adrenal medulla, or paraspinal ganglia. The clinical presentation can vary from an asymptomatic mass to symptoms resulting from local invasion and/or spread of distant disease spread. The natural history of neuroblastoma is highly variable, ranging from relatively indolent biological behavior to a high-risk clinical phenotype with a dismal prognosis. Age, stage, and biological features are important prognostic risk stratification and treatment assignment prognostic factors. The multimodal therapy approach includes myeloablative chemotherapy, radiotherapy, immunotherapy, and aggressive surgical resection. Hyperbaric oxygen therapy (HBOT) has been proposed as a complementary measure to overcome tumor hypoxia, which is considered one of the hallmarks of this cancer treatment resistance. This article aims to review the relevant literature on the neuroblastoma pathophysiology, clinical presentation, and different biological and genetic profiles, and to discuss its management, focusing on HBOT. Frontiers Media S.A. 2023-09-26 /pmc/articles/PMC10562625/ /pubmed/37823059 http://dx.doi.org/10.3389/fonc.2023.1254322 Text en Copyright © 2023 Alpuim Costa, Gonçalves-Nobre, Sampaio-Alves, Guerra, Arana Ribeiro and Espiney Amaro https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Alpuim Costa, Diogo Gonçalves-Nobre, J. Guilherme Sampaio-Alves, Mafalda Guerra, Nuno Arana Ribeiro, Joana Espiney Amaro, Carla Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review |
title | Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review |
title_full | Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review |
title_fullStr | Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review |
title_full_unstemmed | Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review |
title_short | Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review |
title_sort | hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562625/ https://www.ncbi.nlm.nih.gov/pubmed/37823059 http://dx.doi.org/10.3389/fonc.2023.1254322 |
work_keys_str_mv | AT alpuimcostadiogo hyperbaricoxygentherapyasacomplementarytreatmentinneuroblastomaanarrativereview AT goncalvesnobrejguilherme hyperbaricoxygentherapyasacomplementarytreatmentinneuroblastomaanarrativereview AT sampaioalvesmafalda hyperbaricoxygentherapyasacomplementarytreatmentinneuroblastomaanarrativereview AT guerranuno hyperbaricoxygentherapyasacomplementarytreatmentinneuroblastomaanarrativereview AT aranaribeirojoana hyperbaricoxygentherapyasacomplementarytreatmentinneuroblastomaanarrativereview AT espineyamarocarla hyperbaricoxygentherapyasacomplementarytreatmentinneuroblastomaanarrativereview |